No black box warning on record for Irinotecan Hydrochloide

As of the latest FDA labeling reviewed, Irinotecan Hydrochloide (IRINOTECAN HYDROCHLOIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Irinotecan Hydrochloide medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Diarrhea and Cholinergic Reactions: Early diarrhea (occurring during or shortly after infusion of irinotecan hydrochloride injection) is usually transient and may be accompanied by cholinergic symptoms. Consider prophylactic or therapeutic administration of 0.25 mg to 1 mg of intravenous or subcutaneous atropine (unless clinically contraindicated). Late diarrhea (gener

No black box warning on record for Irinotecan Hydrochloide

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Diarrhea and Cholinergic Reactions: Early diarrhea (occurring during or shortly after infusion of irinotecan hydrochloride injection) is usually transient and may be accompanied by cholinergic symptoms. Consider prophylactic or therapeutic administration of 0.25 mg to 1 mg of intravenous or subcutaneous atropine (unless clinically contraindicated). Late diarrhea (gener

Irinotecan Hydrochloide Black Box Warning

No black box warning on record for Irinotecan Hydrochloide

Other warnings & precautions

Irinotecan Hydrochloide Black Box Warning

No black box warning on record for Irinotecan Hydrochloide

Other warnings & precautions